These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22355588)

  • 1. Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor.
    Baier CJ; Fantini J; Barrantes FJ
    Sci Rep; 2011; 1():69. PubMed ID: 22355588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of CARC and CRAC Cholesterol-Recognition Motifs in the Nicotinic Acetylcholine Receptor and Other Membrane-Bound Receptors.
    Di Scala C; Baier CJ; Evans LS; Williamson PTF; Fantini J; Barrantes FJ
    Curr Top Membr; 2017; 80():3-23. PubMed ID: 28863821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-induced acetylcholine receptor clusters inhabit liquid-ordered and liquid-disordered domains.
    Kamerbeek CB; Borroni V; Pediconi MF; Sato SB; Kobayashi T; Barrantes FJ
    Biophys J; 2013 Oct; 105(7):1601-11. PubMed ID: 24094401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charged amino acid motifs flanking each extreme of the alphaM4 transmembrane domain are involved in assembly and cell-surface targeting of the muscle nicotinic acetylcholine receptor.
    Roccamo AM; Barrantes FJ
    J Neurosci Res; 2007 Feb; 85(2):285-93. PubMed ID: 17131427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.
    Arias HR
    Methods Mol Biol; 2010; 606():291-318. PubMed ID: 20013404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes.
    Fantini J; Di Scala C; Evans LS; Williamson PT; Barrantes FJ
    Sci Rep; 2016 Feb; 6():21907. PubMed ID: 26915987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the structure of the nicotinic acetylcholine receptor ion channel with the uncharged photoactivable compound -3H-diazofluorene.
    Blanton MP; Dangott LJ; Raja SK; Lala AK; Cohen JB
    J Biol Chem; 1998 Apr; 273(15):8659-68. PubMed ID: 9535841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for lipid modulation of nicotinic acetylcholine receptor function.
    Barrantes FJ
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):71-95. PubMed ID: 15572164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol effects on nicotinic acetylcholine receptor: cellular aspects.
    Barrantes FJ
    Subcell Biochem; 2010; 51():467-87. PubMed ID: 20213555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking.
    Ren XQ; Cheng SB; Treuil MW; Mukherjee J; Rao J; Braunewell KH; Lindstrom JM; Anand R
    J Neurosci; 2005 Jul; 25(28):6676-86. PubMed ID: 16014729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution conformation of the antibody-bound tyrosine phosphorylation site of the nicotinic acetylcholine receptor beta-subunit in its phosphorylated and nonphosphorylated states.
    Phan-Chan-Du A; Hemmerlin C; Krikorian D; Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Marinou M; Thureau A; Cung MT; Tzartos SJ
    Biochemistry; 2003 Jun; 42(24):7371-80. PubMed ID: 12809492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid matters: nicotinic acetylcholine receptor-lipid interactions (Review).
    Barrantes FJ
    Mol Membr Biol; 2002; 19(4):277-84. PubMed ID: 12512774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic cholesterol depletion hinders cell-surface trafficking of the nicotinic acetylcholine receptor.
    Pediconi MF; Gallegos CE; De Los Santos EB; Barrantes FJ
    Neuroscience; 2004; 128(2):239-49. PubMed ID: 15350637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ligand-gated ion channels by protein phosphorylation.
    Swope SL; Moss SJ; Raymond LA; Huganir RL
    Adv Second Messenger Phosphoprotein Res; 1999; 33():49-78. PubMed ID: 10218114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transmembrane motif governs the surface trafficking of nicotinic acetylcholine receptors.
    Wang JM; Zhang L; Yao Y; Viroonchatapan N; Rothe E; Wang ZZ
    Nat Neurosci; 2002 Oct; 5(10):963-70. PubMed ID: 12219096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.